Royal London Asset Management LTD Moderna, Inc. Transaction History

Royal London Asset Management LTD

$39.4 Billion
Q3 2024

A detailed history of Royal London Asset Management LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Royal London Asset Management LTD holds 339,619 shares of MRNA stock, worth $12.5 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

339,619

Previous 335,309 1.29%

Holding current value

$12.5 Million

Previous $39.8 Million 43.0%

% of portfolio

0.06%

Previous 0.1%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$63.64 - $125.14 $274,288 - $539,353	4,310 Added 1.29%	339,619 $22.7 Million
Q2 2024 Aug 07, 2024	SELL	$101.21 - $166.61 $5.18 Million - $8.53 Million	-51,219 Reduced 13.25%	335,309 $39.8 Million
Q1 2024 May 14, 2024	BUY	$85.37 - $115.44 $1.61 Million - $2.18 Million	18,913 Added 5.14%	386,528 $41.2 Million
Q4 2023 Feb 13, 2024	BUY	$69.51 - $104.43 $593,754 - $892,041	8,542 Added 2.38%	367,615 $36.6 Million
Q3 2023 Nov 14, 2023	SELL	$96.41 - $126.61 $3.1 Million - $4.07 Million	-32,146 Reduced 8.22%	359,073 $37.1 Million
Q2 2023 Aug 11, 2023	SELL	$118.5 - $160.53 $2.25 Million - $3.05 Million	-18,971 Reduced 4.62%	391,219 $47.5 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $20 Million - $29.1 Million	147,774 Added 56.31%	410,190 $63 Million
Q4 2022 Feb 09, 2023	BUY	$118.38 - $210.04 $7.62 Million - $13.5 Million	64,352 Added 32.49%	262,416 $47.1 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $2.52 Million - $4.14 Million	21,337 Added 12.07%	198,064 $23.4 Million
Q2 2022 Aug 12, 2022	BUY	$117.13 - $176.59 $81,053 - $122,200	692 Added 0.39%	176,727 $25.2 Million
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $720,695 - $1.34 Million	5,699 Added 3.35%	176,035 $30.3 Million
Q4 2021 Oct 18, 2022	BUY	$225.82 - $368.51 $11.4 Million - $18.7 Million	50,701 Added 42.38%	170,336 $43.3 Million
Q4 2021 Jan 18, 2022	BUY	$225.82 - $368.51 $11.4 Million - $18.7 Million	50,701 Added 42.38%	170,336 $43.3 Million
Q3 2021 Oct 18, 2022	SELL	$221.9 - $484.47 $465,768 - $1.02 Million	-2,099 Reduced 1.72%	119,635 $46.1 Million
Q3 2021 Nov 02, 2021	SELL	$221.9 - $484.47 $465,768 - $1.02 Million	-2,099 Reduced 1.72%	119,635 $46.1 Million
Q2 2021 Oct 18, 2022	SELL	$129.91 - $234.98 $7.14 Million - $12.9 Million	-54,993 Reduced 31.12%	121,734 $28.6 Million
Q2 2021 Jul 14, 2021	BUY	$129.91 - $234.98 $1.95 Million - $3.53 Million	15,022 Added 14.08%	121,734 $28.6 Million
Q1 2021 Oct 17, 2022	SELL	$109.18 - $185.98 $7.64 Million - $13 Million	-70,015 Reduced 39.62%	106,712 $14 Million
Q1 2021 Apr 13, 2021	BUY	$109.18 - $185.98 $279,173 - $475,550	2,557 Added 2.45%	106,712 $14 Million
Q4 2020 Jan 29, 2021	SELL	$65.74 - $169.86 $203,728 - $526,396	-3,099 Reduced 2.89%	104,155 $10.9 Million
Q3 2020 Nov 04, 2020	BUY	$54.34 - $94.85 $5.83 Million - $10.2 Million	107,254 New	107,254 $7.56 Million

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.

Account

Royal London Asset Management LTD Moderna, Inc. Transaction History